GlassScriptPhysician profile
Andrew Kilday
NPI 1598262867
$2,993.31
in general payments reported to CMS, 2019-2025
17 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $116 · 2023: $389 · 2024: $1,368 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,877.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,337.08 | 2022-2025 | Wavewriter Alpha Prime 16, Accolade Sr, General - Pain Management |
| Forte Bio-Pharma LLC | $328.97 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $232.35 | 2023-2025 | Xtampza, Belbuca |
| Stryker Corporation | $231.36 | 2024-2025 | Mild Device Kit |
| Saluda Medical Americas, INC. | $211.37 | 2024 | Evoke |
| Vertos Medical, INC. | $144.99 | 2024 | Mild Device Kit |
| Nevro Corp. | $136.24 | 2023-2024 | Senza |
| Biotronik Nro, INC. | $99.05 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $85.64 | 2024-2025 | Eterna, Proclaim |
| Globus Medical, INC. | $43.25 | 2025 | Senza |
| Trevena, INC. | $38.27 | 2023 | Olinvyk |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.05 | 2025 | Relistor |
| Averitas Pharma INC. | $20.33 | 2023 | Qutenza |
| Medtronic, INC. | $19.52 | 2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2025 | Zilretta, Iovera |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $14.30 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $11.54 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kilday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.